drugset / Trial / NCT01608464
Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to improve their outcome by either changing the chemotherapy drugs or giving them radiation therapy with concurrent chemotherapy, hoping that this will improve their outcome.
Timeline
- Start
- 2012-05
- Primary completion
- 2015-09
- Completion
- 2015-09
Outcome
Outcome not reported
Stopped (Enrollment): “poor accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Comparator | Docetaxel | Small molecule | 40 mg/m2 | — |
| Comparator | Irinotecan | Small molecule | 100 mg/m2 | Intravenous |
| Subject | fluorouracil | Small molecule | 750 mg/m2 | Intravenous |